TABLE 1.
Compound |
β-Arrestin 2 Recruitment |
Gαi/o Activation |
Gβγ Activation |
Potency (EC50) Ratio |
|||
---|---|---|---|---|---|---|---|
EC50 | Max Effect (% Dopamine) | EC50 | Max Effect (% Dopamine) | EC50 | Max Effect (% Dopamine) | β-Arrestin/Gαi/o | |
nM | nM | nM | |||||
Dopamine | 124 (100–153) | 100 (± 2) | 1.2 (0.7–2.1) | 100 (± 3) | 171 (72–407) | 100 (± 8) | 103 |
Quinpirole | 64 (59–70) | 96 (± 1) | 1.2 (0.9–1.6) | 100 (± 2) | 145 (89–236) | 103 (± 4) | 53 |
Lisuride | 0.4 (0.3–0.6) | 66 (± 2) | 0.07 (0.04–0.14) | 106 (± 5) | 2.2 (0.4–12.0) | 30 (± 6) | 9 |
Bromocriptine | 2.9 (1.9–4.4) | 101 (± 4) | 1.9 (0.9–4.3) | 104 (± 3) | 0.5 (0.1–2.1) | 34 (± 5) | 2 |
Aripiprazole | 3.6 (2.5–5.2) | 19 (± 1) | 1.3 (0.5–3.1) | 65 (± 4) | ND | −19 (± 5) | 3 |
Rotigotine | 0.2 (0.1–0.3) | 111 (± 4) | 0.02 (0.007–0.03) | 95 (± 3) | 1.5 (0.3–6.9) | 54 (± 9) | 10 |
(+)-3-PPP | 925 (809–1058) | 92 (± 1) | 8.6 (4.9–15.1) | 108 (± 4) | 518 (136–1973) | 57 (± 9) | 108 |
RNPA | 1.9 (1.5–2.5) | 101 (± 2) | 13 (3–57) | 95 (± 13) | 360 (210–619) | 110 (± 11) | 0.1 |
Pramipexole | 12 (10–15) | 94 (± 2) | 0.2 (0.1–0.3) | 108 (± 3) | 20 (9–46) | 86 (± 5) | 60 |
Ropinirole | 49 (37–63) | 92 (± 2) | 0.5 (0.3–0.8) | 111 (± 4) | 100 (34–290) | 56 (± 6) | 98 |
Pergolide | 7.2 (5.9–8.9) | 90 (± 2) | 0.04 (0.02–0.07) | 101 (± 4) | 2.3 (0.6–9.5) | 38 (± 7) | 180 |
ND, not determined.